Prof Gs answer Q: The evidence regarding GLP-1 use and safety in people with MS YES Q: Whether the metabolic benefits alone justify considering them in someone with my profile YES For information on why I am saying yes and yes, the following is a more detailed discussion on the evidence of the therapeutic potential of GLP-1 receptor agonists in MS and what I think about the HCPs attitudes to your requests.
Under homeostatic conditions, lactate entering neurons via the ANLS pathway is efficiently oxidized by mitochondria to generate ATP, maintaining lactylation modifications at a low basal state to ensure the prioritization of cellular energy metabolism (Allen and Lyons, 2018)
Clean Ingredients: No fillers, artificial preservatives, or refined sugarsjust real, whole foods
Preventing blood sugar spikes and crashes , which trigger cravings
Subtherapeutic dosing or failure to titrate appropriately can limit efficacy
10.3390/molecules25081862 46 JohnsonC.ProkopienkoA